Amie Simmons

Associate
Full contact info

Passions

Trail Running

NBA Basketball

Experience

Cooley Secures Dismissal of Derivative Action for FibroGen

October 9, 2024

Cooley successfully secured the complete dismissal of a derivative action for FibroGen – a biopharmaceutical company that discovers and develops medicines for the treatment of anemia, cancer and fibrotic disease – as well as certain officers and directors. The case is In re FibroGen Inc. Derivative Litigation, C.A. No. 2022-0331-SG (Del. Ch.).

Read more

Related contacts

Patrick Gibbs
Partner, Palo Alto
Tijana Brien
Partner, Palo Alto
Brett De Jarnette
Partner, Palo Alto
Amie Simmons
Associate, Palo Alto
Kimberley Scimeca
Associate, Boston
Madeleine McNally
Associate, Palo Alto

Related Practices & Industries

Cooley Files Amicus Brief Supporting Continued Application of the Internal Affairs Doctrine in New York

March 28, 2024

Cooley filed an amicus brief in the New York Court of Appeals on behalf of 47 corporate law professors in support of the continued application of the internal affairs doctrine.

Read more

Related contacts

Kathleen R. Hartnett
Partner, San Francisco
Patrick J. Hayden
Special Counsel, New York
Samantha Kirby
Associate, Palo Alto
Alex Kasner
Associate, Washington, DC
Amie Simmons
Associate, Palo Alto
Madeleine McNally
Associate, Palo Alto

Related Practices & Industries

Cooley Secures Win for FibroGen in Securities Fraud Class Action

March 15, 2024

Cooley successfully narrowed the class period, thereby substantially reducing the plaintiffs’ potential damages, in a securities class action against client FibroGen – a biopharmaceutical company that discovers and develops medicines for the treatment of anemia, cancer and fibrotic disease.

Read more

Related contacts

Patrick Gibbs
Partner, Palo Alto
Tijana Brien
Partner, Palo Alto
Brett De Jarnette
Partner, Palo Alto
Alexandra Eber
Associate, Washington, DC
Caitlin B. Munley
Associate, Washington, DC
Amie Simmons
Associate, Palo Alto
Kimberley Scimeca
Associate, Boston

Related Practices & Industries

Ninth Circuit Affirms BioMarin’s Win in Securities Class Action

February 26, 2024

Cooley secured a win on behalf of BioMarin Pharmaceutical before the US Court of Appeals for the Ninth Circuit. The win affirmed a 2023 dismissal of a putative class action alleging violations of the Securities Exchange Act of 1934.

Read more

Related contacts

Patrick Gibbs
Partner, Palo Alto
John C. Dwyer
Partner, Palo Alto
Brett De Jarnette
Partner, Palo Alto
Samantha Kirby
Associate, Palo Alto
Amie Simmons
Associate, Palo Alto

Related Practices & Industries

Cooley Wins Release of Wrongfully Incarcerated Father

February 7, 2022

Cooley partnered with the Northern California Innocence Project to secure the release of Kevin Harper Jr., who was wrongfully convicted for the death of his infant son in 2008. Harper’s wrongful conviction, which resulted in a sentence of 25 years to life, was based on medical evidence that has since been widely discredited. A recent change in California’s AB 1540 law paved the way for the Sacramento District Attorney’s Office to re-review Kevin’s case. This allowed for a petition to resentence and release Harper, ending his 13-year incarceration in late January.

Related contacts

Patrick Gibbs
Partner, Palo Alto
Jessie Simpson LaGoy
Associate, Palo Alto
Samantha Kirby
Associate, Palo Alto
Janelle Fernandes
Associate, Colorado
Amie Simmons
Associate, Palo Alto

Admissions and credentials

California